Blood cancer research (IMAGE)

Virginia Tech

Blood cancer research

Caption

Cancer researchers including senior author Christopher Hourigan (left) and first author Rasha Al-Ali of Virginia Tech’s Fralin Biomedical Research Institute found that a highly sensitive DNA-based test may help doctors predict which patients with acute myeloid leukemia (AML) are most likely to relapse. 

Credit

Lena Ayuk/Virginia Tech

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.